Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab for subclinical enthesitis in moderate to severe plaque psoriasis
2012-002640-25Phase 4Completed
- Sponsor
- University of Leeds
- Start
- Jan 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ustekinumab in plaque psoriasis and psoriatic disease, sponsored by University of Leeds. Primary endpoint: Change in enthesopathy measurements by ultrasound. Started Jan 2013; status: completed.
02
Drugs
ustekinumab
03
Conditions
plaque psoriasispsoriatic disease
Beyond the preview
Go deeper on 2012-002640-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002640-25.